1.Osborn,Anne G.
Brain Osborn’s Brain: Imaging,Pathology and Anatomy.1sted: Amirsyr Publishing,Inc;2013:978-991.
2.Rohini Nadgir,
David M.Yousem.Neuroradiology.4thed.The Requisites;2017:243-246.
3.
Olfati N,
Shoeibi A,
Litvan I.
Progress in the treatment of Parkinson-Plus
syndromes.
Parkinsonism RelatDisord.
2018 Oct 3.
pii: S1353-8020(18)30432-2.
4.
Flabeau O,
Meissner WG,
Tison F.
Multiple system atrophy: current and future approaches to management.
TherAdvNeurolDisord.
2010;3(4):249-63.
5.
Boxer AL,
Yu JT,
Golbe LI,
Litvan I,
Lang AE,
Höglinger GU.
Advances in progressive supranuclear palsy: new diagnostic criteria,
biomarkers,and therapeutic approaches.
Lancet Neurol.
2017 Jul;16(7):552-563.
6.
Armstrong MJ.
Diagnosis and treatment of corticobasal degeneration.
Curr Treat Options Neurol.
2014 Mar;16(3):282.
7.
De la Fuente-Fernández R.
Role of DaTSCAN and clinical diagnosis in Parkinson disease.
Neurology.
2012 Mar 6;78(10):696-701.
8.
Agosta F,
Galantucci S,
Filippi M.
Advanced magnetic resonance imaging of neurodegenerative diseases.
Neurol Sci.
2017 Jan;38(1):41-51.
9.
Schwarz ST,
Afzal M,
Morgan PS et-al.
The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T.
PLoS ONE.
2014;9 (4): e93814.
10.
Kim HJ,
Jeon B,
Fung VSC.
Role of Magnetic Resonance Imaging in the Diagnosis of Multiple System Atrophy.
Mov Disord Clin Pract.
2016;4(1):12-20.
Published 2016 Jul 28.
11.
McFarland NR.
Diagnostic Approach to Atypical Parkinsonian Syndromes.
Continuum (Minneap Minn).
2016;22(4 Movement Disorders):1117-42.
12.
V.C.
Constantinides,
G.P.
Paraskevas,
G.
Velonakis,
P.
Toulas,
E.
Stamboulis and E.
Kapaki,
MRI Planimetry and Magnetic Resonance Parkinsonism Index in the Differential Diagnosis of Patients with Parkinsonism American Journal of Neuroradiology June 2018,
39 (6) 1047-1051
13.
Grijalvo-Perez AM and I Litvan.
Corticobasal Degeneration.
Semin Neurol.
2014;34 (02): 160–73.